The Mid-Atlantic Section of the American Urological Association has met annually since 1941. This year the meeting is in Baltimore and offers the opportunity for urologists in practice, small and large hospitals to meet, share ideas and build lasting relationships. This year the Brady Urological Institute is well-represented. Some of the highlights include:
|Arthur L. Burnett, MD, MBA|
- A special topic lecture by Arthur Burnett on the "Efficacy of Early Penile Rehabilitation Following Radical Prostatectomy: Myth or Reality," Thursday, 3pm.
- Point/Counterpoint sessions led by:
- Stephen Schatz on Endoscopic Management of BPH, Friday, 10:45am
- Trinity Bivalacqua on BCG Refractory Superficial Bladder Cancer, Friday, 4:00pm
- Video Case Discussion of laparoscopic and robotic complications by Christian Pavlovich and Misop Han
A full schedule of the Brady events are listed below.
To see the full listing of presentations and abstracts click here.
ThurSDAY, September 18
SCIENTIFIC SESSION 1: 2-3pm6. Percent Lymph Node Involvement Predicts Mortality after Inguinal Lymph Node Dissection for Penile Cancer. Mark W. Ball, Joan Ko, Deborah Kaye, George Netto, Stephania Bezerra, Arthur L Burnett, Trinity Bivalacqua.
MODERATED POSTER SESSION 1: 2-3pmMP7. Sickle Cell Disease in Priapism: Disparities in Care? Gregory A. Joice, Max Kates, Nikolai Sopko, Johanna Hannan, Trinity Bivalacqua.
MP9. Quantification of Feulgen Stain (DNA) Nuclear Morphometry Predicts Prostate Cancer Aggressiveness. Aniq ur rehman Gajdhar, Guangjing Zhul, James E. Verdone, Christine Davis, Jonathan I. Epstein, Robert W. Veltri.
MP11. A Human Prostatic Bacterial Isolate Alters the Prostatic Microenvironment and Accelerates Prostate Cancer Progression. Brian W. Simonsl, Nicholas M. Durham, Tullia Bruno, Joseph Grosso, Anthony Schaeffer, Ashley E. Ross, Paula Hurley, David M. Berman, Charles G. Drakel, Praveen Thumbikaf, Edward M. Schaeffer.
DISPLAY POSTERS: 2P-8PP5. Rnaseh2a Roles In Regulating Prostate Cancer Cell Cycle And Survival. Zhenhua Huang, Sr., Edward Schaeffer, Sr., Ashley Ross.
P15. Priapism Impact Profile (PIP) Questionnaire: Development and Initial Evaluation. Arthur L Burnett, Uzoma A. Anele, Irene N. Trueheart.
P17. Identification of Men With The Highest Risk of Early Disease Recurrence After Radical Prostatectomy. Debasish Sundi, Vinson Wang, Phillip M. Pierorazio, Misop Han, Alan W. Partin, Phuoc Tran, Ashley E. Ross, Trinity Bivalacqua.
P19. Robotic Retroperitoneal Lymph Node Dissection for Clinical Stage I NSGCT: Initial Study of Feasibility and Comparative Analysis. Mark W. Ball, GautamJayram, MichaelA. Gorin, Phillip M. Pierorazio, Mohamad E. Allaf.
P20. Grade Reclassification on Active Surveillance: Age Matters. Jeffrey Tosoian, Bruce Trock, Max Kates, Patricia Landis,Jonathan I. Epstein, H. Ballentine Carter.
P23. National Resource Utilization In Radical Cystectomy For Bladder Cancer. Jen Jane Liu, Nilay Gandhi, Christian Pavlovich, Trinity Bivalacqua.
P24. Glycolysis Is Necessary For Cell Motility And Cytoskeleton Remodeling In Epithelial To Mesenchymal Transition In Prostate Cancer Cells. Takumi Shiraish P,Jessie Huang, James E. Verdone, James Hernandez', Steven M. Mooney, StevenS. An, Kennth J. Pienta.
P25. Predicting the Risk of Non Organ Confined Prostate Cancer When Perineural Invasion Is Found on Biopsy. Michael A. Gorin, Heather Chalfin, Jonathan I. Epstein, Zhaoyong Feng, Alan W. Partin, Bruce Trock.
P27. Secondary Re Closure in Classic Bladder Exstrophy: The Johns Hopkins Experience. Brian M. Inouye, Heather N. DiCarlo, Ezekiel E. Young, Ali Tourchi,John Gearhart.
SPECIAL TOPIC LECTURE: 3-345p"Efficacy of Early Penile Rehabilitation Following Radical Prostatectomy: Myth or Reality" -- Presenter: Arthur Burnett, M.D.
SCIENTIFIC SESSION 2: 330-4pm
8. 5-year Analysis of A MultiInstitutional, Prospective Clinical Trial of Delayed Intervention And Surveillance For Small Renal Masses: The Dissrm Registry. Phillip M. Pierorazio, MichaelA. Gorin, Mark W. Ball, Bruce Trock, Mohamad E. Allaf.
14. Do PreBiopsy Rectal Swabs for FluoroquiQolone Resistance Reduce Prostate BiopsyRelated Infections? Jason E. Michaud, Aniq Gajdhar, Lucinda Robinson, Stephen M. Schatz, Pravin K. Rao, E. James Wright, Christian P. Pavlovich.
MODERATED POSTER SESSION 2: 3:45-4-45pmMP14. Phenotypic Heterogeneity in Small Renal Masses. Mark W. Ball, Stephania Bezerra, Michael A. Gorin, Christian P. Pavlovich, Phillip M. Pierorazio, George]. Netto, Mohamad E. Allaf.
MP16. Risk Factors for IntraProstatic Incision Into Malignant Glands at Radical Prostatectomy Nathaniel Readal, SungWoo Park, Bruce Trock, Elizabeth Humphreys, Jonathan I. Epstein, Alan W. Partin, Misop Han.
MP17. Predict Prostate Cancer Aggression with Multiple Biomarkers Using a Novel Quantitative Tissue Immunoassay. Guangjing Zhul, Zhi Uu, Christhunesa S. Christudass,Jonathan I. Epstein, Hui Zhang, Joon Yong Chung, Stephen M. Hewitt, Robert W. Veltri.
MPI5. Erectile Dysfunction after Recurrent Ischemic Priapism in Patients With and Without Sickle Cell Disease: A Characterization and Comparative Analysis of Risk Factors. Uzoma A. Anele, Irene N. Trueheart, Arthur L Burnett.
MP22. The Financial Impact of Robotic Technology for Partial and Radical Nephrectomy. Max Kates, Mark W. Ball, Hiten D. Patel, Michael A. Gorin, PhillipP. Pierorazio, Mohamad E. Allaf.
MP24. Increased a actin and TGFj31 Levels in Bladder Exstrophy Smooth Muscle Cells. Ezekiel E. Young', Eric Z Massanyi, Heather DiCarlo, Brian Inouye, John P. Gearhart, Larissa A. Shimoda.
FRIDAY, September 19
SCIENTIFIC SESSION 3: 745-9am21. Long:-term Erectile Function Outcomes of Patients In A Randomized Controlled Trial of Nightly Vs OnDemand Penile Rehabilitation With Sildenafil After Nerve sparing Radical Prostatectomy. Nilay M. Gandhi, Lynda Z. Mettee, Zhaoyong Feng, Bruce Trock, Christian P. Pavlovich.
22. Variability in Medicare Utilization and Payment Among Urologists. Joan S. Ko, Heather Chalfin, Bruce Trock, Zhaoyong Feng, Elizabeth Humphreys, Sung-Woo Park, H. Ballentine Carter, Misop Han.
POINT-COUNTERPOINT: 1045-1130amEndoscopic Management of Benign Prostatic Hyperplasia (BPH):Greenlight KTP laser vs. Bipolar TURP -- Moderator: Stephen Schatz, MD
Greenlight KTP: Gregg Eure, M.D. Urology of Virginia, Virginia Beach, VA
Bipolar TURP: William Jaffe, M.D. Penn Presbyterian Medical Center, Philadelphia, PA
VIDEO CASE PANEL DISCUSSION: 2-3pmManagement of Intraoperative Laparoscopic and Robotic Complications (or what to do when the sh.. hits the fan)
Moderators: Misop Han, M.D., Johns Hopkins Hospital, Baltimore, MD; Christian Pavlovich, M.D., Johns Hopkins, Baltimore, MD
David Chen, M.D., Fox Chase Cancer Center, Rockledge, PA
Costas Lallas, M.D., Thomas Jefferson University, Philadelphia, PA
Thomas Jarrett, M.D., George Washington University, Washington, DC
SCIENTIFIC SESSION 4: 3-4pm25. Robotic Simple Prostatectomy for Symptomatic Large-Gland BPH: Safety, Feasibility, and Comparative Analysis. Mark W. Ball, GautamJayram, Christian P. Pavlovich, Misop Han.
28. Neoadjuvant Chemotherapy Prediction of Extravesical Cancer Control Based Off Pathologic Staging. Nilay M. Gandhi, Alex Baras,Jen Jane-Uu, Mark Schoenberg, George Netto, Trinity Bivalacqua.
30. African American Race is Associated with Adverse Oncologic Outcomes Following Prostatectomy: LongrTerm Follow Up. Farzana Faisal, Debasish Sundi, Ashley Ross, Elizabeth R Humphreys, Alan W. Partin, Misop Han, Edward M. Schaeffer.
POINT-COUNTERPOINT: 4-445pmBCG Refractory Superficial Bladder Cancer: Early Cystectomy vs.Salvage Intravesical Therapy
Moderators: Matthew Kaag, M.D., Penn State Hershey Medical Center, Hershey, PA
Early Cystectomy: Thomas Guzzo, M.D., University of Pennsylvania, Philadelphia, PA
Salvage Intravesical Therapy: Trinity Bivalacqua, M.D., Ph.D., Johns Hopkins Medical Center, Baltimore, MD
CURE YOUR SICKNESS AND DISEASE WITH HERBAL CURE FROM AFRICA.ReplyDelete
Are you in pains or can not find cure for your sickness or disease? Wipe your tears, we are here to cure you of whatever disease or sickness you are battling right now.
We specialize in all kind of treatment and with the help of Almighty God you will be well again, hurry now and contact us via email: firstname.lastname@example.org
HEALTH IS WEALTH.
I was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
liver already present. I started on antiviral medications which
reduced the viral load initially. After a couple of years the virus
became resistant. I started on HEPATITIS B Herbal treatment from
ULTIMATE LIFE CLINIC (www.ultimatelifeclinic.com) in March, 2020. Their
treatment totally reversed the virus. I did another blood test after
the 6 months long treatment and tested negative to the virus. Amazing
treatment! This treatment is a breakthrough for all HBV carriers.